AzTrials
AzTrials

Post Intensive Care SyndromeNCT02706457

Post Intensive Care Syndrome

An observational study of Post Intensive Care Syndrome and Barthel Index, run by Frisius Medisch Centrum at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Barthel Index and demographic variables of patients were collected to investigate the question whether the improvements of the functionality improves the Barthel Index over the years. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post Intensive Care Syndrome, Barthel Index
What is being tested?
Barthel index for functionality
How many people
849 participants
Where
1 siteNetherlands
Study dates
Oct 2015to Apr 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients treated in Intensive Care for minimal 48 hours, during the years 2012 - 2014

Who may be able to join

  • 18 years and older
  • length of stay longer than 48 hours

Who cannot join

  • no exclusion criteria if inclusion is correct

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Medical Center Leeuwarden

    Leeuwarden, 8904 BR

Other trials in Netherlands

About this study

Official title: Do Improvements in Functionality on the ICU Give a Reduction of Post Intensive Care Syndrome

Barthel Index and demographic variables of patients were collected to investigate the question whether the improvements of the functionality improves the Barthel Index over the years.

Read the detailed description

idem

Being tested
Barthel index for functionality
Keywords
intensive care, functionality
Medical subject headings
postintensive care syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Barthel index for functionalityOther

    The Barthel Index for functionality is done standard in all patients after intensive care admission

Study groups in NCT02706457
Study groupRoleWhat they receive
cohort 2012 - 2014all patients admitted for > 48 hours on the Intensive Care Unit in 2012, 2013 and 2014
Receives: Other: Barthel index for functionality

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in Barthel Index

    barthel index is analyzed over the years 2012 - 2014

    Measured: from januari 2012 until decembre 2014

Secondary outcomes (1)
  1. Relation between Barthel Index and length of stay in ICU

    Measured: from januari 2012 until decembre 2014

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2016 (estimated)
  2. Study startOct 2015
  3. Primary completionApr 2016
  4. Study completionApr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
849 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02706457
Sponsor's protocol ID
nWMO 143
Status last verified
Apr 2016
First submitted
16 Feb 2016
Last updated
12 Apr 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post Intensive Care Syndrome and Barthel Index, run by Frisius Medisch Centrum at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in Barthel Index (time frame: from januari 2012 until decembre 2014). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in